Richtlijn CVRM feb2013 - KNMP

Cohen 2012a Cohen JD, Brinton EA, Ito MK, Jacobson TA.Understanding Statin Use in America and Gaps in
Patient Education (USAGE): an internet-based survey of 10,138 current and former statin
J Clin Lipidol. 2012 May;6(3):208-15.
users.
Cohen 2012b
Cohen A, Drost P, Marchant N, Mitchell S, Orme M, Rublee D. The efficacy and safety of
pharmacological prophylaxis of venous thromboembolism following elective knee or hip
replacement: systematic review and network meta-analysis. Clin Appl Thromb Hemost 2012;
PMID: 22387582
Colhoun 2004 Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary
prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative
Atorvastatin Diabetes Study (CARDS): multicentre randomized placebo-controlled trial. Lancet 2004;
364: 685-96.
Compagne 2010 Compagne-de Jong AJJ, Otoide-Vree M en van Hessen MWJ, Vrouwen en een (niet-) herkend
acuut coronair syndroom. Hartbulletin 2010 (41): 40-43.
Connolly 2009
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus
warfarin in patients with atrial Fibrillation. N Eng J Med 2009; 361: 1139-51.
Costanzo 2009 Constanzo P, Perrone-Filardi P, Petretta M, Marciano C, Vassallo E, Garguilo P, Paolillo S, Petretta A,
Chiariello M. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634
patients. J Hypertens 2009; 27: 1136-1151.
Cutler 1997
Cutler J, Follmann D, Alexander PS. Randomised controlled trials of sodium reduction: a
overview. Am J Clin Nutr 1997; 65: 643-651.
D’Agostino 1991 D’Agostino RB, Belanger AJ, Kannel WB and Cruickshank JM. Relation of low diastolic
bloodpressure tot coronary heart disease death in presence of myocardial infarction: the
Framingham study. Brit Med J 1991; 303: 385-389.
Daemen 2012 Daemen J, van Geuns RJ, Zijlstra F. stand van zaken: meer dan 25 jaar coronaire stents.
NTVG 2012; 156 (50): 2135-2140.
Dahlöf 2005
Datillo 1992
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular
events with an antihypertensive regimen of amlodipine adding peridopril as required versus atenolol
adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood
Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366:
895-906.
Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a
meta-analysis. Am J Clin Nutr 1992; 56: 320-328.
Davidson 2007 Davidsoon MH, Robinson JG. Safety of aggressive lipid management. J Am Coll Cardiol 2007; 49: 1753-
62.
Delaney 2007
Dentali 2007
Dep.of Health
Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug drug interaction between antithrombotic
medications and the risk of gastro-intestinal bleeding. CMAJ 2007; 177 (4): 347-351.
Dentali F, Douketis JD, Lim W, Crowther M. Combined aspririn-oral anticoagulant therapy alone
among patients at risk for cardiovascular disease. Arch Intern Med 2007; 167: 117-24.
Rapport “Pharmacy in England, Building on strengths-delivering the future”, uitgegeven door
Department of Health. Te raadplegen op: www.officialdocuments.gov.uk/documents/cm73/7341/7341.pdf
Dippel 2004
Dippel DWJ en vander Worp HB. Preventie van vasculaire complicaties na een TIA of beroerte:
bloeddruk- en cholesterolverlagende therapie. NTvG 2004; 148: 820-824.
Dis van 2009 Dis van I, Kromhout D, Geleijnse JM et al. Body mass index and waist circumference predict both
10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20.000 Dutch men
and women aged 20-65 years. Eur J Cardiovasc Prev Rehabil 2009; 16: 729-734.
86
CONCEPT